Mining giant Vedanta is set to demerge four businesses into separate listed entities, with May 1 as the record date. Shareholders will receive one share of each new company for every Vedanta share held. While listing dates are unannounced, past demergers suggest a timeline of 3 weeks to several months.Read More
Shares of Cohance Lifesciences surged 20% on Monday after the appointment of former Cipla CEO Umang Vohra as its new Executive Chairman and Group CEO. His leadership is expected to drive transformation, scale operations, and strengthen global partnerships as the company enters its next growth phase.Read More
Paytm shares are set to remain in focus after the RBI cancelled Paytm Payments Bank’s licence, prompting its closure. The company expects no material impact due to the prior separation. While Bernstein flags concerns over regulatory tone, it retains a positive view, seeing limited business disruption and potential licensing opportunities ahead.Read More
Sun Pharmaceutical Industries’ shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in women’s health. This strategic move aims to bolster Sun Pharma’s innovative medicines business and establish it as a top-tier player in biosimilars and women’s health globally.Read More
Goldman Sachs has raised oil price forecasts due to severe inventory draws caused by the Strait of Hormuz closure. Analysts predict Brent crude will average $90 a barrel in Q4, citing massive Persian Gulf production losses. The ongoing conflict is significantly impacting global supply, leading to record drawdowns and threatening inflation.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
